about
sameAs
P184
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingCerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcomeThe effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of KenyaAn immune basis for malaria protection by the sickle cell trait.Genome-wide and fine-resolution association analysis of malaria in West AfricaSickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseasesEfficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of ageMolecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in AfricaVolume status in severe malaria: no evidence provided for the degree of filling of the intravascular compartmentPlasmodium falciparum variant surface antigen expression patterns during malariaHeritability of malaria in AfricaAge, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational StudyA genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in KenyaTemporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaImmunity to non-cerebral severe malaria is acquired after one or two infectionsTransient cross-reactive immune responses can orchestrate antigenic variation in malariaA phase 3 trial of RTS,S/AS01 malaria vaccine in African infantsCISH and susceptibility to infectious diseasesA phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in KenyaClearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan childrenDeclining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coastPopulation genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assayGenome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressureProfile: The Kilifi Health and Demographic Surveillance System (KHDSS)Serological evidence of discrete spatial clusters of Plasmodium falciparum parasitesCircumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malariaSafety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian ChildrenImputation-based meta-analysis of severe malaria in three African populations.Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologuePeripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialGenome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in KenyaThe role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion.Plasmodium falciparum var gene expression homogeneity as a marker of the host-parasite relationship under different levels of naturally acquired immunity to malaria.Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Defining childhood severe falciparum malaria for intervention studiesHaemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.Helminth infection and eosinophilia and the risk of Plasmodium falciparum malaria in 1- to 6-year-old children in a malaria endemic area.Evidence for over-dispersion in the distribution of clinical malaria episodes in children.
P50
Q20901697-A509252B-2D7B-4A87-BA40-09DBFA106F37Q21032453-17D62105-D5BB-4091-BD47-B53D8349859DQ21144709-D1F30EB9-9555-48D6-B03B-79FC16B2A940Q21144724-7237D69D-5AE3-47D7-818F-6DE7AE9A2BA3Q24632119-CF44A932-D90E-44A5-8690-C8E66E2C2C51Q24632966-45C57A8D-8DC2-4607-8439-11F82AB0A33EQ24658073-E51133E4-8D41-4CF6-B016-C562759DB66DQ24806194-471BCB47-6C82-44A1-8F75-4F0D240B7816Q24809237-204C0F43-1E3B-444E-9EF9-9BC06C408693Q24811060-D7B24DCC-B56C-462B-A4C0-5359FA68EAC1Q24814424-5584E941-8043-4659-92DA-951B889A2435Q27306991-13663E1E-8F20-404D-B74B-776BF6556C09Q28031418-698F07DA-6437-445C-A652-6B0BE4E6D516Q28125914-2FE4B5E9-0CB6-479B-926C-63FE3C88E87EQ28139257-974EA6AB-F73B-4CA9-A100-A5B5F9F2CBECQ28264776-D5DE2588-818B-4B92-8E99-1F7FCE779406Q28278852-3D7830EF-D5B2-4E35-AD21-973AB1089F49Q28282872-00EBD537-F844-4B2B-9AD2-130631866B5AQ28469062-ECCD73D4-F2E5-4238-9894-47A2E9F326FEQ28477259-7ABC2982-28A4-4B02-BAEE-A2E4256AD817Q28477892-DC99B703-17A4-4470-AAE2-B24366E604CBQ28478444-661B6795-5985-44B6-BE22-EEA40C36C9CDQ28481274-89FCAB1E-B6A4-4B4A-B0BC-349641EF3939Q28727170-6BAC5018-554B-4E93-8E46-50CA444EB1B2Q28743081-4B57792F-DDEC-4C6D-AAF0-62743F7C6E32Q28744170-7DEC6712-0ABC-47A3-90F0-DA52051390E2Q28744573-76302F7D-8CCF-4833-AEB6-D2FCB5ADDC11Q29417086-BDFB3309-721B-4994-9E4E-F41663CAABAFQ30042486-45260947-4EAD-4DF0-9A7B-8BE010143ABCQ30662529-9AFE5FC6-1750-4523-8320-B46E6F88FDB2Q30991737-FDB8EE8A-C389-4EDF-9E52-243A284B1AC3Q31076495-1A8486AF-5278-4A86-B856-770D241CBE2CQ31103497-57F13A77-3F45-4D1C-8F88-64AF0EB2540FQ31125954-84085939-BD4C-4324-BCCD-E2D4EC58E65AQ31169310-A19D146E-AEDB-42C2-AE34-752B66C540BDQ33294698-93CF88E9-CE9B-4EAB-85F2-96CFDBED64B5Q33294896-3B7BD776-A502-4E2C-8D42-7C7FB7595DE3Q33301333-E7894559-43EC-4E45-9F8F-A50AE2DABF05Q33319239-4F444C4E-23CC-4572-B879-7B5DDE0169D5Q33336415-56CE605B-CDD3-4D56-A4B7-573AEF2E49BF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kevin Marsh
@ast
Kevin Marsh
@en
Kevin Marsh
@es
Kevin Marsh
@nl
Kevin Marsh
@sl
type
label
Kevin Marsh
@ast
Kevin Marsh
@en
Kevin Marsh
@es
Kevin Marsh
@nl
Kevin Marsh
@sl
altLabel
K Marsh
@en
K. Marsh
@en
Marsh K
@en
Marsh K.
@en
Marsh
@en
prefLabel
Kevin Marsh
@ast
Kevin Marsh
@en
Kevin Marsh
@es
Kevin Marsh
@nl
Kevin Marsh
@sl
P106
P185
P21
P31
P496
0000-0001-8377-5466